<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Current Computer-Aided Drug Design</journal-id><journal-title-group><journal-title xml:lang="en">Current Computer-Aided Drug Design</journal-title><trans-title-group xml:lang="ru"><trans-title>Current Computer-Aided Drug Design</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1573-4099</issn><issn publication-format="electronic">1875-6697</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">644057</article-id><article-id pub-id-type="doi">10.2174/1573409919666230523155830</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Chemistry</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Network Pharmacology Combined with GEO Analysis of the Mechanism of Qing-Jin-Hua-Tan Decoction in the Treatment of Non-small Cell Lung Cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Yi</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Chao</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff id="aff1"><institution>Department of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine</institution></aff><aff id="aff2"><institution>Department of Medical Image, Qingdao Hospital of Traditional Chinese Medicine (Qingdao Hiser Hospital)</institution></aff><pub-date date-type="pub" iso-8601-date="2024-04-01" publication-format="electronic"><day>01</day><month>04</month><year>2024</year></pub-date><volume>20</volume><issue>4</issue><issue-title xml:lang="ru"/><fpage>396</fpage><lpage>404</lpage><history><date date-type="received" iso-8601-date="2025-01-07"><day>07</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/1573-4099/article/view/644057">https://journals.eco-vector.com/1573-4099/article/view/644057</self-uri><abstract xml:lang="en"><p id="idm46041443820864">Background:Non-small-cell lung cancer (NSCLC) is one of the most prevalent malignancies and poses a significant threat to human health. Qing-Jin-Hua-Tan (QJHT) decoction is a classical herbal remedy that has demonstrated therapeutic effects in various diseases, including NSCLC, and can improve the quality of life of patients with respiratory conditions. However, the mechanism underlying the effect of the QJHT decoction on NSCLC remains unclear and requires further investigation.</p><p id="idm46041443824864">Methods:We collected NSCLC-related gene datasets from the GEO database and performed differential gene analysis, followed by using WGCNA to identify the core set of genes associated with NSCLC development. The TCMSP and HERB databases were searched to identify the active ingredients and drug targets, and the core gene target datasets related to NSCLC were merged to identify the intersecting targets of drugs and diseases for GO and KEGG pathway enrichment analysis. We then constructed a protein-protein interaction (PPI) network map of drug diseases using the MCODE algorithm and identified key genes using topology analysis. The disease-gene matrix underwent immunoinfiltration analysis, and we analyzed the association between intersecting targets and immunoinfiltration.</p><p id="idm46041443828832">Results:We obtained the GSE33532 dataset that met the screening criteria, and a total of 2211 differential genes were identified using differential gene analysis. We performed GSEA analysis and WGCNA analysis for a crossover with differential genes, resulting in 891 key targets for NSCLC. The drug database was screened to obtain 217 active ingredients and 339 drug targets of QJHT. By constructing a PPI network, the active ingredients of QJHT decoction were intersected with the targets of NSCLC, resulting in 31 intersected genes. Enrichment analysis of the intersection targets showed that 1112 biological processes, 18 molecular functions, and 77 cellular compositions were enriched in GO functions, and 36 signaling pathways were enriched in KEGG pathways. Based on immune-infiltrating cell analysis, we found that the intersection targets were significantly associated with multiple infiltrating immune cells.</p><p id="idm46041443833888">Conclusion:Our analysis using network pharmacology and mining of the GEO database revealed that QJHT decoction can potentially treat NSCLC through multi-target and multi-signaling pathways, while also regulating multiple immune cells.</p></abstract><kwd-group xml:lang="en"><kwd>Qing-Jin-Hua-Tan decoction</kwd><kwd>non-small cell lung cancer</kwd><kwd>network pharmacology</kwd><kwd>GEO database</kwd><kwd>CIBERSORT</kwd><kwd>herbal remedy.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Siegel, R.L.; Miller, K.D.; Wagle, N.S.; Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin., 2023, 73(1), 17-48. doi: 10.3322/caac.21763 PMID: 36633525</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Nasim, F.; Sabath, B.F.; Eapen, G.A. Lung Cancer. Med. Clin. North Am., 2019, 103(3), 463-473. doi: 10.1016/j.mcna.2018.12.006 PMID: 30955514</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Duma, N.; Santana-Davila, R.; Molina, J.R. NonSmall Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin. Proc., 2019, 94(8), 1623-1640. doi: 10.1016/j.mayocp.2019.01.013 PMID: 31378236</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Herbst, R.S.; Morgensztern, D.; Boshoff, C. The Biology and Management of Non-small Cell Lung Cancer. Nature, 2018, 553(7689), 446-454. doi: 10.1038/nature25183 PMID: 29364287</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>VanderLaan, P.A.; Roy-Chowdhuri, S. Current and Future Trends in Non-small Cell Lung Cancer Biomarker Testing: The American Experience. Cancer Cytopathol., 2020, 128(9), 629-636. doi: 10.1002/cncy.22313 PMID: 32885913</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wu, F.; Wang, L.; Zhou, C. Lung Cancer in China: Current and Prospect. Curr. Opin. Oncol., 2021, 33(1), 40-46. doi: 10.1097/CCO.0000000000000703 PMID: 33165004</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Luo, T.; Lu, Y.; Yan, S.; Xiao, X.; Rong, X.; Guo, J. Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective. Chin. J. Integr. Med., 2020, 26(1), 72-80. doi: 10.1007/s11655-019-3064-0 PMID: 30941682</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Nogales, C.; Mamdouh, Z.M.; List, M.; Kiel, C.; Casas, A.I.; Schmidt, H.H.H.W. Network Pharmacology: Curing Causal Mechanisms Instead of Treating Symptoms. Trends Pharmacol. Sci., 2022, 43(2), 136-150. doi: 10.1016/j.tips.2021.11.004 PMID: 34895945</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zhang, R.; Zhu, X.; Bai, H.; Ning, K. Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Front. Pharmacol., 2019, 10, 123. doi: 10.3389/fphar.2019.00123 PMID: 30846939</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Barrett, T.; Wilhite, S.E.; Ledoux, P.; Evangelista, C.; Kim, I.F.; Tomashevsky, M.; Marshall, K.A.; Phillippy, K.H.; Sherman, P.M.; Holko, M.; Yefanov, A.; Lee, H.; Zhang, N.; Robertson, C.L.; Serova, N.; Davis, S.; Soboleva, A. NCBI GEO: Archive for Functional Genomics Data Sets-Update. Nucleic Acids Res., 2013, 41(Database issue), D991-D995. PMID: 23193258</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ritchie, M.E.; Phipson, B.; Wu, D.; Hu, Y.; Law, C.W.; Shi, W.; Smyth, G.K. Limma Powers Differential Expression Analyses for RNA-sequencing and Microarray Studies. Nucleic Acids Res., 2015, 43(7), e47. doi: 10.1093/nar/gkv007 PMID: 25605792</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ru, J.; Li, P.; Wang, J.; Zhou, W.; Li, B.; Huang, C.; Li, P.; Guo, Z.; Tao, W.; Yang, Y.; Xu, X.; Li, Y.; Wang, Y.; Yang, L. TCMSP: A Database of Systems Pharmacology for Drug Discovery from Herbal Medicines. J. Cheminform., 2014, 6(1), 13. doi: 10.1186/1758-2946-6-13 PMID: 24735618</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Fang, S.; Dong, L.; Liu, L.; Guo, J.; Zhao, L.; Zhang, J.; Bu, D.; Liu, X.; Huo, P.; Cao, W.; Dong, Q.; Wu, J.; Zeng, X.; Wu, Y.; Zhao, Y. HERB: A High-throughput Experiment and Reference-Guided Database of Traditional Chinese Medicine. Nucleic Acids Res., 2021, 49(D1), D1197-D1206. doi: 10.1093/nar/gkaa1063 PMID: 33264402</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Langfelder, P.; Horvath, S. WGCNA: An R Package for Weighted Correlation Network Analysis. BMC Bioinformatics, 2008, 9(1), 559. doi: 10.1186/1471-2105-9-559 PMID: 19114008</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Bateman, A.; Martin, M-J.; Orchard, S.; Magrane, M.; Agivetova, R.; Ahmad, S.; Alpi, E.; Bowler-Barnett, E.H.; Britto, R.; Bursteinas, B.; Bye-A-Jee, H.; Coetzee, R.; Cukura, A.; Da Silva, A.; Denny, P.; Dogan, T.; Ebenezer, T.G.; Fan, J.; Castro, L.G.; Garmiri, P.; Georghiou, G.; Gonzales, L.; Hatton-Ellis, E.; Hussein, A.; Ignatchenko, A.; Insana, G.; Ishtiaq, R.; Jokinen, P.; Joshi, V.; Jyothi, D.; Lock, A.; Lopez, R.; Luciani, A.; Luo, J.; Lussi, Y.; MacDougall, A.; Madeira, F.; Mahmoudy, M.; Menchi, M.; Mishra, A.; Moulang, K.; Nightingale, A.; Oliveira, C.S.; Pundir, S.; Qi, G.; Raj, S.; Rice, D.; Lopez, M.R.; Saidi, R.; Sampson, J.; Sawford, T.; Speretta, E.; Turner, E.; Tyagi, N.; Vasudev, P.; Volynkin, V.; Warner, K.; Watkins, X.; Zaru, R.; Zellner, H.; Bridge, A.; Poux, S.; Redaschi, N.; Aimo, L.; Argoud-Puy, G.; Auchincloss, A.; Axelsen, K.; Bansal, P.; Baratin, D.; Blatter, M-C.; Bolleman, J.; Boutet, E.; Breuza, L.; Casals-Casas, C.; de Castro, E.; Echioukh, K.C.; Coudert, E.; Cuche, B.; Doche, M.; Dornevil, D.; Estreicher, A.; Famiglietti, M.L.; Feuermann, M.; Gasteiger, E.; Gehant, S.; Gerritsen, V.; Gos, A.; Gruaz-Gumowski, N.; Hinz, U.; Hulo, C.; Hyka-Nouspikel, N.; Jungo, F.; Keller, G.; Kerhornou, A.; Lara, V.; Le Mercier, P.; Lieberherr, D.; Lombardot, T.; Martin, X.; Masson, P.; Morgat, A.; Neto, T.B.; Paesano, S.; Pedruzzi, I.; Pilbout, S.; Pourcel, L.; Pozzato, M.; Pruess, M.; Rivoire, C.; Sigrist, C.; Sonesson, K.; Stutz, A.; Sundaram, S.; Tognolli, M.; Verbregue, L.; Wu, C.H.; Arighi, C.N.; Arminski, L.; Chen, C.; Chen, Y.; Garavelli, J.S.; Huang, H.; Laiho, K.; McGarvey, P.; Natale, D.A.; Ross, K.; Vinayaka, C.R.; Wang, Q.; Wang, Y.; Yeh, L-S.; Zhang, J.; Ruch, P.; Teodoro, D. UniProt: The Universal Protein Knowledgebase in 2021. Nucleic Acids Res., 2021, 49(D1), D480-D489. doi: 10.1093/nar/gkaa1100 PMID: 33237286</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ke, W.; Zhang, L.; Dai, Y. The Role of IL‐6 in Immunotherapy of Non‐small Cell Lung Cancer (NSCLC) with Immune‐related Adverse Events (irAEs). Thorac. Cancer, 2020, 11(4), 835-839. doi: 10.1111/1759-7714.13341 PMID: 32043828</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Scott, L.J. Tocilizumab: A Review in Rheumatoid Arthritis. Drugs, 2017, 77(17), 1865-1879. doi: 10.1007/s40265-017-0829-7 PMID: 29094311</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Li, Q.; Han, Y.; Fei, G.; Guo, Z.; Ren, T.; Liu, Z. IL-17 Promoted Metastasis of Non-small-cell Lung Cancer Cells. Immunol. Lett., 2012, 148(2), 144-150. doi: 10.1016/j.imlet.2012.10.011 PMID: 23089548</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Wagner, N.; Wagner, K.D. PPAR Beta/Delta and the Hallmarks of Cancer. Cells, 2020, 9(5), 1133. doi: 10.3390/cells9051133 PMID: 32375405</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Yang, J. PPAR-γ Silencing Inhibits the Apoptosis of A549 Cells by Upregulating Bcl-2 Zhongguo Fei Ai Za Zhi, 2013, 16(3), 125-130. PMID: 23514940</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Chuang, C.H.; Yeh, C.L.; Yeh, S.L.; Lin, E.S.; Wang, L.Y.; Wang, Y.H. Quercetin Metabolites Inhibit MMP-2 Expression in A549 Lung Cancer Cells by PPAR-γ Associated Mechanisms. J. Nutr. Biochem., 2016, 33, 45-53. doi: 10.1016/j.jnutbio.2016.03.011 PMID: 27260467</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lim, K.H.; Staudt, L.M. Toll-like Receptor Signaling. Cold Spring Harb. Perspect. Biol., 2013, 5(1), a011247. doi: 10.1101/cshperspect.a011247 PMID: 23284045</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Pahlavanneshan, S.; Sayadmanesh, A.; Ebrahimiyan, H.; Basiri, M. Toll-Like Receptor-Based Strategies for Cancer Immunotherapy. J. Immunol. Res., 2021, 2021, 1-14. doi: 10.1155/2021/9912188 PMID: 34124272</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Tran, T.H.; Tran, T.T.P.; Truong, D.H.; Nguyen, H.T.; Pham, T.T.; Yong, C.S.; Kim, J.O. Toll-like Receptor-targeted Particles: A Paradigm to Manipulate the Tumor Microenvironment for Cancer Immunotherapy. Acta Biomater., 2019, 94, 82-96. doi: 10.1016/j.actbio.2019.05.043 PMID: 31129358</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Wang, K.; Wang, J.; Wei, F.; Zhao, N.; Yang, F.; Ren, X. Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy. Front. Immunol., 2017, 8, 456. doi: 10.3389/fimmu.2017.00456 PMID: 28484456</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Tavora, B.; Mederer, T.; Wessel, K.J.; Ruffing, S.; Sadjadi, M.; Missmahl, M.; Ostendorf, B.N.; Liu, X.; Kim, J.Y.; Olsen, O.; Welm, A.L.; Goodarzi, H.; Tavazoie, S.F. Tumoural Activation of TLR3SLIT2 Axis in Endothelium Drives Metastasis. Nature, 2020, 586(7828), 299-304. doi: 10.1038/s41586-020-2774-y PMID: 32999457</mixed-citation></ref></ref-list></back></article>
